Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
Revance Therapeutics is a biotechnology company specializing in aesthetic and therapeutic neuromodulator products, including DAXXIFY and the RHA Collection of dermal fillers. The company develops, manufactures, and commercializes innovative injectables for facial wrinkles, muscle disorders, and other indications. It partners globally for distribution and biosimilar development, focusing on long-lasting, natural-looking treatments that enhance patient and physician experiences across markets.
This description was generated via AI from an annual report. Updated about 1 year ago.